Sage Journals: Discover world-class research

Abstract

Complete evaluation of the toxicity of a new chemical entity requires critical analysis of the pattern of positive and negative findings in all types of toxicity tests, pharmacokinetics and metabolism in the species examined, and correlation of the effects with information about its pharmacodynamic and pharmacological properties. The goal is to obtain sufficient understanding of the mechanisms underlying the therapeutic and toxic effects of the compound to permit a well-supported extrapolation from the test to the target species. The Expert Report system in the European Community is based on comprehensive 25-page reviews of information about a compound arranged under 3 headings: Chemistry and Pharmacy, Pharmacology and Toxicology, and Clinical Studies. Each section requires a searching review of the experimental work and the relevant literature, integration of the findings, and then careful correlation among these 3 main areas of knowledge to indicate the circumstances of safe and effective use of the drug.

Keywords

Pharmacology toxicology pharmacokinetics drug registration European Community regulatory mechanism

References

1. 65/65/EEC (1965). Council Directive on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Off. J. Eur. Comm. No. 22, 9.2.1965, p. 369/65.

2. 75/318/EEC (1975). Council Directive on the approximation of the Laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. Off. J. Eur. Comm. No. L 147, 9.6.1975, p. 1.

3. 83/570/EEC (1983). Council Directive amending Directives 65/65/EEC and 75/319/EEC on the approximation of the provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Off. J. Eur. Comm. No. L 332, 28.11.1983, p. 1.

4. 87/22/EEC (1987). Council Directive on the approximation of national measures relating to the placing on the market of high-technology medicinal products, particularly those derived from biotechnology. Off. J. Eur. Comm. No. L 15, 17.1.1987, p. 30.

5. Cook T , Doyle C , and Jabbari D (1991). Pharmaceuticals, Biotechnology and the Law. Stockton Press, New York, pp. 188–199.

Integrating Safety Data: The Expert Report

Abstract

Keywords

References